ExoCoBIO Co.

BiotechnologySeries CSeoul, South Koreaexocobio.com

Latest round

Series C

Last raised

Aug 2020

Total raised

$47M

Investors

16

About ExoCoBIO Co.

, Ltd. operates in the regenerative medicine sector, focusing on exosome technologies. Yong Yi is the founder, while Byong-seung Cho serves as CEO. ExoCoBIO specializes in exosome-based regenerative therapeutics and bio-pharmaceuticals, primarily utilizing its proprietary ExoSCRT™ technology. This innovation enables the production of high-purity, high-efficacy exosomes for a range of applications including aesthetic treatments and immuno-oncology. Their product lineup includes advanced skincare solutions like ASCE+ Skin and ASCE+ Hair, along with specialized formulations such as Exomage and Celosome, targeting dermatologists and healthcare providers in Asia, North America, and Europe.3, reflecting its successful sales model focused on direct sales and partnerships within the aesthetic and medical fields. ExoCoBIO plans to launch new advanced products designed to expand its portfolio of exosome-based solutions.

Who invested in ExoCoBIO Co.

16 investors across 3 rounds

See all investors in ExoCoBIO Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Aug 25, 2020

    Amount

    $9.3M

    Investors

    Locked

  2. Series B

    Sep 12, 2018

    Amount

    $27M

    Investors

    Locked

  3. Series A

    May 2, 2017

    Amount

    $11M

    Investors

    Locked

Questions about ExoCoBIO Co.

Who invested in ExoCoBIO Co.?

ExoCoBIO Co. has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ExoCoBIO Co. raised?

ExoCoBIO Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did ExoCoBIO Co. last raise money?

ExoCoBIO Co.'s most recent round on record is a Series C, in Aug 2020.

What does ExoCoBIO Co. do?

ExoCoBIO Co. is a biotechnology company.

Where is ExoCoBIO Co. headquartered?

ExoCoBIO Co. is headquartered in Seoul, South Korea.

Which VCs invest in companies like ExoCoBIO Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ExoCoBIO Co.'s stage. Their profiles are linked below.

Raising like ExoCoBIO Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.